MedPath

Pulmonary Hypertension in Connective Tissue Disorders

Not Applicable
Registration Number
CTRI/2024/03/063822
Lead Sponsor
Aditi Rao
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with connective tissue disorders- systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis, sjogrens disease, dermatomyositis, polymyositis, mixed connective tissue disorder, undifferentaited connective tissue disorder, behcets disease

Exclusion Criteria

Left Heart disease due to valvular heart disease, congenital heart disease , Chronic lung disease or hypoxia due to chronic obstructive pulmonary disease and sleep disordered breathing, Chronic pulmonary thromboembolism , chronic hemolytic anemia , myeloproliferative disorders, Systemic and metabolic disorders like glycogen storage disease, Gaucher disease, pulmonary Langerhans cell histiocytosis, lymphangioleiomyomatosis, and neurofibromatosis, fibrosing mediastinitis, Portal hypertension, retro viral disease, schistosomiasis or 2D echocardiogram unavailable any time within in the study period.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath